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The factors that initiate human labor are poorly understood. We have tested the hypothesis that
adecline in cAMP/proteinkinaseA (PKA) function leads to theonsetof labor. Initially,we identified
myometrial cAMP/PKA-responsive genes (six up-regulated and five down-regulated genes) and
assessed their expression in myometrial samples taken from different stages of pregnancy and
labor.We found that theoxytocin receptor (OTR)wasoneof the cAMP-repressedgenes, and, given
the importance of OTR in the labor process, we studied the mechanisms involved in greater detail
using small interfering RNA, chemical agonists, and antagonists of the cAMP effectors. We found
that cAMP-repressed genes, including OTR, increased with the onset of labor. Our in vitro studies
showed that cAMP acting via PKA reduced OTR expression but that in the absence of PKA, cAMP
acts via exchange proteins activated by cAMP (EPAC) to increase OTR expression. In early labor
myometrial samples, PKA levels and activity declined and Epac1 levels increased, perhaps account-
ing for the increase in myometrial OTR mRNA and protein levels at this time. In vitro exposure of
myometrial cells to stretch and IL-1 increased OTR levels and reduced basal and forskolin-stim-
ulated cAMP and PKA activity, as judged by phospho-cAMP response element-binding protein
levels, but neither stretch nor IL-1 had any effect on PKA or EPAC1 levels. In summary, there is a
reduction in the activity of the cAMP/PKA pathway with the onset of human labor potentially
playing a critical role in regulating OTR expression and the transition frommyometrial quiescence
to activation.
The mechanisms responsible for the onset of human la-bor are uncertain. However, it seems likely that myo-
metrial cAMP levels contribute to the maintenance of
myometrial quiescence because hormones that increase
cAMP levels promote myometrial quiescence (1) and
-sympathomimetics, which increase myometrial cAMP
levels, havebeenused clinically todelaydelivery inwomen
presenting in preterm labor (2) and to reverse prostaglan-
din induced uterine tachysystole (3). Indeed, others have
documented changes in the cAMP pathway that would
result in a reduction in cAMP action with the onset of
labor (4–7); however, most of these studies have been
based on samples taken in established labor and the re-
duction in components of the cAMP pathway therefore
may be a consequence rather than a cause of the onset of
labor.
Although changes in cAMP action may be involved in
labor onset, most theories regarding the onset of human
labor are based on a reduction in progesterone action. In
the human, in contrast tomost animal models, circulating
progesterone levels do not decline before the onset of la-
bor, although changes inmyometrial gene expression sug-
gest that progesterone action is reduced (8–10). Various
theories to explain the reduction in progesterone action
have been formulated including a negative interaction be-
tween the progesterone receptor and nuclear factor-B
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(11, 12), a change in the balance of progesterone receptor
isoform levels, or an increase in local progesterone me-
tabolism and have all been suggested to be responsible for
the decline in progesterone action (13–15). Alternatively,
we recently demonstrated that progesterone action, both
in terms of transactivation and transrepression of gene
expression, is enhanced by the action of cAMP (16), rais-
ing the possibility that progesterone influence may be re-
duced by a decline in cAMP action.
In this study, we have tested the hypothesis that myo-
metrial cAMP/proteinkinaseA (PKA)actiondeclineswith
advancing gestation and in early labor to define whether
a decline in cAMP action occurs before the onset of labor
and may therefore contribute to the onset of labor. Ini-
tially, we defined which genes were regulated by cAMP in
myometrial cells, finding that the expression of cAMP-
repressed genes increased in early labor, consistent with a
decline in cAMP/PKA action. Importantly, we found that
oxytocin receptor (OTR) was one of the genes that were
strongly repressed by cAMP. Given the importance of
OTR in human labor, we extended our study to examine
the interaction between cAMPandOTR, identifying a key
molecular switch that reverses cAMP/PKA inhibition of
OTR expression and perhaps accounting for the increase
in OTR expression with the onset of human labor.
Materials and Methods
Patient selection
Approval for the collection of myometrial biopsies was ob-
tained fromLondon-ChelseaCommittee 10/H0801/45. Fully in-
formed written consent was sought from all patients participat-
ing in the study. Biopsies were obtained from the upper margin
of the uterine lower segment incision at the time of uncompli-
cated cesarean section from different groups of nonlaboring and
laboring women at Chelsea andWestminster Hospital (London,
United Kingdom). Women were recruited from the following
defined groups: preterm not in labor (24–36 wk), term not in
labor (TNL; 37 wk), term early labor (three to four contrac-
tions in 10 min and 3 cm dilated), and term established labor
(three to four contractions in 10min and 3 cm dilated; n 12
in each group). The indications for lower segment cesarean sec-
tion in the laboring group were for fetal distress or breech pre-
sentation. There was no evidence of slow progress of labor or
cephalopelvic disproportion and all without oxytocin infusion.
In the nonlaboring group, indications include previous lower
segment cesarean section, breech presentation, and maternal
request.
Tissue specimens and cell culture
Myometrial biopsies (0.5 cm3) obtained from the four dif-
ferent groups of women were snap frozen immediately after col-
lection at 80°C for protein and mRNA extraction. For myo-
metrial cell culture, themyometrial biopsies from theTNLgroup
were then put into DMEM (PA4 9RF; Invitrogen) containing
L-glutamine and 100 mU/mL penicillin and 100 mg/mL strep-
tomycin and were stored at 4°C for no more than 3 hours prior
to cell preparation for culture (17).Thebiopsiesweremincedand
digested for about 45 minutes at 37°C in a collagenase solution,
which included 0.5mg/mL collagenase 1A andXI (Sigma) and 1
mg/mL BSA in DMEMmedium (Sigma). Digestion was stopped
by the addition of DMEM supplemented with 7.5% fetal calf
serum. Themyometrial tissue suspensionwas agitated to further
disperse the cells. The resulting suspension was then passed
through a cell strainer (70mnylon cell strainer), and individual
cells were collected by centrifugation at 3000 rpm for 5minutes.
After washing, cells were grown in DMEMwith the supplemen-
tation of 7.5% fetal calf serum, 1% L-glutamine, and 1% pen-
icillin-streptomycin at 37°C in an atmosphere consisting of 5%
CO2. Themyometrial cells usedwere either in the third or fourth
passages. The cells were serum starved overnight in 1%dextran-
coated charcoal, supplemented with L-glutamine, 100 mU/mL
penicillin, and 100 g/mL streptomycin), approximately 18–24
hoursprior to the initiationof experiments. In all cases, at the end
of the specified time, the medium was removed and cells were
frozen at 80°C for extraction of mRNA and protein.
Materials
In the following experiments, we use the different treatments
and the final concentration of them were as follows: IL-1, 1
ng/mL (Sigma-Aldrich Co Ltd); forskolin, 100 M (Sigma-Al-
drichCoLtd); sp-6-phe-cAMP (PKAagonist, 100 nM; BIOLOG
Life Science Institute, Bremen, Germany); 8pCPT-2-O-Me-
cAMP (exchange proteins activated by cAMP [Epac] agonist, 50
M; BIOLOG Life Science Institute); 5-amino-imidazole-4-car-
boxamide-1--D-ribofuranoside (AMP-activatedproteinkinase
[AMPK] agonist, 100 M; Merck Chemicals Ltd); KT5720
(PKA inhibitor, 10 M; Sigma-Aldrich Co Ltd); brefeldin A
(Epac inhibitor, 100 M; Sigma-Aldrich Co Ltd); compound C
(AMPK inhibitor 100 M;Merck Chemicals Ltd); fluo-4 direct
calcium assay kits (F10471; Invitrogen); oxytocin (100 nM; Al-
liance); 8-bromoadenosine-cAMP8(250M;Sigma-AldrichCo
Ltd); dibutyryl-cAMP (50M;Sigma-AldrichCoLtd); rolipram
(10 M; Sigma-Aldrich Co Ltd); and aminophylline (10 M;
Sigma-Aldrich Co Ltd).
Forskolin array
Cells from TNL biopsies were cultured and incubated with
and without 100 M forskolin for 48 hours and RNA extracted
and subjected toAffimetrixHumanGenomeU133plus2.0array
gene analysis. A total of 28 870 genes were interrogated (n 3).
Two gene lists were generated by combining the top 50 up-reg-
ulated and down-regulated genes.Only those geneswithP .05
and fold change greater than 1.5 were analyzed. Of the genes
altered by forskolin, five genes that were down-regulated
(PRKG1, GUCY1A3, GPR124, cAMP response element-bind-
ing protein [CREB)]-3L1,OTR) (Supplemental Table 1) and six
genes that were up-regulated (MKP-1, 11HSD1, PTGES,
PDE4B, GPR125, CCL8) (Supplemental Table 2) were ana-
lyzed in the myometrial tissues obtained from the different
groups of women by quantitative PCR (qPCR) and Western
blotting.
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RNA extraction, cDNA synthesis, and qPCR
RNAextraction, cDNAsynthesis, andqPCRwere performed
as previously reported (17). Primer sets for genes listed in Sup-
plemental Table 3 were designed and obtained from Invitrogen
Ltd. Total RNAs were extracted and purified from human cells
using RNA easy mini kits (catalog number 74106; QIAGEN
Ltd).With regard to the RNA extraction frommyometrial tissue
samples, myometrial tissue samples were homogenized in 700
L of RNA stat using the Precellys24 dual system. The samples
were placed in a Precellys tube typeCKmix number 03961–1-00
and shaken at 5000 rpm for 20 seconds. Samples were then
centrifuged on a bench top centrifuge at 4°C for 20minutes. The
supernatant was transferred to a new eppendorf and 150 L of
chloroform added and mixed by vortexing. The mixture was
then centrifuged again on a bench top centrifuge at 4°C for 20
minutes. The supernatant was then transferred to a clean eppen-
dorf and total RNA extracted and purified using RNeasy mini-
kits described above. After RNA quantification, 1.0 g was re-
verse transcribed with oligodeoxythymidine random primers
usingMoloneymurine leukemia virus reverse transcriptase (Ap-
plied Biosystems Ltd). Assays were validated for all primer sets
by confirming that single amplicons of appropriate size, and
sequence were generated according to predictions. qPCR was
performed in the presence of SYBR Green (Applied Biosystems
Ltd), and the amplicon yield was monitored during cycling in a
RotorGene sequence detector (Corbett Research Ltd,Mortlake)
that continually measures fluorescence caused by the binding of
the dye to double-stranded DNA. The pre-PCR cycle was 10
minutes at 95°C followed by up to 45 cycles of 95°C for 20
seconds, 58°C-60°C for 20 seconds and 72°C for 20 seconds
followed by an extension at 72°C for 15 seconds. The final pro-
cedure involves a melt over the temperature range of 72°C-99°C
rising by 1° steps with a wait for 15 seconds on the first step
followed by a wait of 5 seconds for each subsequent step. The
cycle in which fluorescence reached a preset threshold (cycle
threshold) was used for quantitative analyses. The cycle thresh-
old in each assay was set at a level at which the exponential
increase in amplicon abundance was approximately parallel be-
tween all samples. All mRNA abundance data were expressed
relative to the amount of constitutively expressed glyceralde-
hyde-3-phosphate dehydrogenase (GAPDH).
Whole-cell protein extraction
Monolayers of humanmyometrial cellswere lysed in cell lysis
buffer obtained from New England BioLabs Ltd, scraped, and
collected in eppendorf tubes. Samples were centrifuged at
13 000  g for 15 minutes at 4°C. The supernatants were then
transferred and stored at 80°C.
Cytosolic/nuclear protein extraction
Cells were trypsinized in 0.25% trypsin containing 0.02%
EDTA in PBS, and the cell pellet was resuspended with cytosolic
buffer A (10 mMHEPES, 10 mMKCl, 0.1 mMEDTA, 0.1 mM
EGTA, 2 mM dithiothreitol, 1% [vol/vol] Nonidet P-40, com-
plete protease inhibitor tablets [Roche]) and incubated on ice for
20minutes. Lysateswere vortexed for 10 seconds at a high speed
followed by centrifugation at 16 000 g for 30 seconds at 4°C.
The supernatants were reserved as the cytosolic protein extracts.
Thepelletswere resuspended innuclearbufferB (10mMHEPES,
10 mMKCl, 0.1 mM EDTA, 0.1 mM EGTA, 2 mM dithiothre-
itol, 400 mM NaCl, 1% Nonidet P-40 [vol/vol], complete pro-
tease inhibitor tablets [Roche]) and incubated on ice for 15 min-
utes with shaking (200 rpm). Subsequently the suspensionwas
centrifuged for 5 minutes at 16 000  g at 4°C. After the last
centrifugation, the supernatant (nuclear extract)was transferred
to a separate tube. These can be used directly or stored at80°C.
Protein extraction for myometrial tissue
Myometrial tissues were placed in a Precellys tube type CK
mix number 03961–1-00with homogenized in five volumes of a
buffer containing 20mMTris-HCl (pH7.4), 150mMNaCl, 1%
Triton X-100, 1 mM EDTA, 1 mM EGTA, 2.5 mM sodium
pyrophosphate, 1 mM -glycerophosphate, 2 mM dithiotreitol,
1 mM Na3VO4, 1 mM phenylmethylsulphonyl fluoride, and 1
g/mL leupeptin. After centrifugation for 1 minute at 12 000
g, homogenates were aliquoted and frozen at 80°C. Protein
concentrations were determined by a protein assay (Bio-Rad
Laboratories) and BSA reference standards. Electrophoresis was
carriedoutusing15-galiquotsofprotein samples in2 loading
buffer (4% sodium dodecyl sulfate; 20% glycerol; 1% 2-mer-
captoethanol; 0.004% bromophenol blue; and 0.125 mol/L
Tris-HCl, pH 6.8). Samples were boiled for 5 min, quenched on
ice and subsequently run on precast 10% sodium dodecyl sul-
fate-polyacrylamide gels (Bio-Rad Laboratories).
Western blotting
Western blottingwas performed as previously described (17).
Antibodies used are listed in Supplemental Table 4. Protein sam-
ples were denatured by heating to 80°C for 10 minutes and run
on a 10% SDS-PAGE for 30 minutes at 100 V and then 40–60
minutes at 150 V, followed by a transfer to a Hybond ECL
nitrocellulose membrane (GE Healthcare UK Ltd). The mem-
brane was blocked with 5% milk protein solution for 1 hour,
washed, and incubated with the primary antibody overnight at
4°C. Subsequently the membrane was incubated with the sec-
ondary antibody at room temperature for 2 hours. For enhanced
chemiluminescence detection of horseradish peroxidase, ECL
plus (GE Healthcare UK Ltd) was used. Exposure for detection
was at 25°C for 1–5 minutes.
Transient transfection
Cells were cultured in six-well plates to about 80% conflu-
ence and then transfected by using primary smooth muscle cells
nucleofector kits transfection reagent (Lonza) according to the
manufacturer’s protocol as previously described (17). The rele-
vant small interferingRNAs (siRNAs) are listed in Supplemental
Table 5. Based on preliminary transfection experiments, after
transfection of relevant siRNAs, themediumwas changed to one
containing 7.5% serum, and then after another 48 hours, the
cells were serum starved in 1% dextran-coated charcoal, sup-
plemented with L-glutamine, 100 mU/mL penicillin, and 100
g/mL streptomycin). The next day, the cells were treated under
different conditions for 6 hours. At the end of the specified time,
the medium was removed and cells were frozen at 80°C for
extraction of mRNA and protein.
Measurement of intracellular cAMP
Myometrial tissue was ground in a mortar and pestle under
liquid nitrogen, and a cAMP assay was subsequently performed
using the cAMP chemiluminescent immunoassay kit (Arbor As-
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says) following themanufacturer’s instructions. The lysates (100
L) were used to measure the levels of cAMPwith a competitive
immunoassay kit (Assay Designs) according to the manufactur-
er’s instructions. Each treatmentwas performed in duplicate and
experiments were repeated at least two times. In another set of
experiment, the cells supernatants were collected at the end of
treatments and stored at 80°C. cAMP levels were measured
from the stored supernatants using an assay kit (cAMP assay;
R&D Systems) following the manufacturer’s instructions.
Measurement of intracellular calcium levels
Myocytes were plated onto 35-mm glass-bottomed dishes
(Greiner Bio One Ltd). Cells were loaded with the calcium dye
Fluo-4-AM Direct (Invitrogen) for 30 minutes at 37°C in a hu-
midified 5%CO2 incubator and then at room temperature for a
further 30minutes. Cells were imaged using a TCS-SP5 confocal
microscope (Leica) with a20 dry objective. Cells were imaged
for approximately 2 minutes before oxytocin treatment and
10–15 minutes after oxytocin addition, capturing every 1.2 sec-
onds. Time-lapse movies and fluorescent intensity plots were
generated with the Leica LASAF software.
Stretch
When cellswere approximately 80%confluent, the cellswere
plated onto six-well, flexible-bottom culture plates precoated
with collagen type I in 2 mL of DMEMmedium for stretch (17).
After 24–48 hours, the cells were subjected to a static stretch of
11% using a Flexercell strain unit (for more details, please see
http://www.flexcellint.com/; Flexcell International Corp). The
cells were stretched for a total of 30 hours. After being stretched
for 24hours, the cellswere incubatedwith andwithout forskolin
(100 	) in the absence and presence of IL-1 (1 ng/mL). The
cells were then stretched again for 6 hours. Unstretched cells
grown and treated similarly were used as controls.
Statistical analysis
All data were initially tested for normality using a Kolmogo-
rov-Smirnoff test. Normally distributed data were analyzed us-
ing a Student’s t test for two groups and anANOVA followed by
a Dunnett’s or Bonferroni’s post hoc test for three groups or
more. Data that were not normally distributed were analyzed
using a Wilcoxon matched-pair test for paired data and when
comparing three groupsormore aFriedman’s test,with aDunn’s
multiple comparisons post hoc test. P  .05 was considered
statistically significant.
Results
A functional assessment of myometrial cAMP
action with the onset of labor
We exposed primary myometrial cell cultures to fors-
kolin 100Mfor 6 hours and used a gene array to identify
the cAMP-responsive genes (please see Supplemental Re-
sults for more details); five genes were down-regulated by
forskolin,PRKG1,GUCY1A3,GPR124,CREB3L1, and
OTR, and six genes were up-regulated by forskolin,
MKP-1, 11HSD1, PTGES, PDE4B, GPR125, and
CCL8 (Supplemental Tables 1 and 2). We confirmed the
ability of forskolin (Supplemental Figure 1) and assessed
the ability of other cAMP agonists, 8-bromoadenosine-
cAMP (Supplemental Figure 2), dibutyryl-cAMP (Supple-
mental Figure3), and rolipram(Supplemental Figure4), to
reproduce the changes in gene expression observed in the
gene array experiment. The details of the behavior of these
genes in myometrial samples obtained at different stages
of pregnancy and labor (Supplemen-
tal Figures 5 and 6). The repressed
genes behaved most consistently,
with four of five, increasing with ad-
vancing gestation and the onset of
labor (Supplemental Figures 6). Im-
portantly, in the case of OTR, the
changes in mRNA were accompa-
nied by a similar change in protein
levels (Figure 1, A and B).
cAMPs act via PKA to reduce
OTR mRNA expression in
human myometrial cells
Initially we confirmed that fors-
kolin (100 M) increased myome-
trial cell cAMP and PKA activity by
measuring cytoplasmic and nuclear
phospho-CREB levels (Supplemen-
tal Figure 7) and also confirmed that
forskolin reduced OTR mRNA ex-
pression and protein levels (Figure 2,
Figure 1. Myometrial OTR levels are up-regulated with term labor. Human myometrial tissue
samples were collected from different groups of nonlaboring and laboring women at the time of
cesarean section. Women were recruited in four defined groups: preterm not in labor (PTNL; 24–
36 wk), TNL (37 wk), term early labor (TEaL; three to four contractions in 10 min and  3 cm
dilated cervix), and term established labor (TEsL; three to four contractions in 10 min and  3 cm
dilated cervix). Samples were snap frozen and stored at 80°C until mRNA and protein
extraction. The levels of OTR mRNA (A) and protein (B) were measured using quantitative RT-PCR
and Western blotting, respectively. A representative Western blot is shown above the graph
displaying the densitometry of the protein levels. Blots were probed with OTR, and GAPDH was
used as a loading control. Data are shown as the median and interquartile range superimposed
on individual data points and were compared using a Friedman’s test, with a Dunn’s multiple
comparisons post hoc test for data that were not normally distributed and using ANOVA with
Bonferroni’s posttest for data that were normally distributed. #, P  .05, ##, P  .01 (n  12 in
each group).
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Figure 2. cAMP acts via PKA to reduce OTR in human primary myometrial cells. A, Myometrial cells were isolated from myometrial biopsies
obtained from women at the time of term prelabor cesarean section. Cells were cultured and incubated with forskolin (100 M) for 6 hours. OTR
mRNA levels were measured using RT-PCR. B, In a separate experiment, myometrial cells were incubated with forskolin (100 M) for 6 hours. OTR
protein levels were measured using Western blotting. C and D, In separate experiments, myometrial cells were cultured, and PKAC-, EPAC1, and
AMPK were knocked down using siRNA, controlled with nontargeted siRNA (siNT). After transfection, cells were cultured for 96 hours before
being treated with forskolin (100 M) for 6 hours; mRNA (C) and protein (D) were extracted, and the levels of OTR mRNA and protein were
measured using RT-PCR and Western blotting, respectively. In separate experiments, myometrial cells were incubated with forskolin (100 M),
KT5720 (10 M), brefeldin A (100 M), or compound C (100 M), either alone or in combination for 6 hours. The levels OTR mRNA (E) and
proteins (F) were measured using RT-PCR and Western blotting, respectively. Data are shown as the median and interquartile range superimposed
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A and B). Then we confirmed that the reduction in OTR
was functionally relevant, showing that it was associated
with a reduction in oxytocin-induced calcium mobiliza-
tion (Supplemental Figure 8). We also confirmed that dif-
ferent cAMP agonists (8-bromoadenosine-cAMP, dibu-
tyryl-cAMP, rolipram, and aminophylline) are able to
decrease OTR mRNA expression (Supplemental Figure
9). Next, we used siRNA knockdown to reduce the ex-
pression of the cAMP effectors PKA, Epac1, and AMPK
and found that the knockdown of PKA blocked the fors-
kolin-induced reduction in OTR mRNA expression and
protein synthesis (Figure 2, C and D). To confirm the
knockdown data, myometrial cells were incubated with
forskolin (100 M) alone or in the presence of cAMP
effector antagonists: PKA(KT5720, 10M),Epac (brefel-
din A, 100 M), and AMPK (compound C, 100 M).
Only the PKA inhibitor could reverse the forskolin-in-
duced reduction in OTR mRNA expression and protein
synthesis (Figure 2, E and F). Similarly, the PKA-specific
agonist reduced OTR mRNA expression (Supplemental
Figure 10A) and protein synthesis (Supplemental Figure
10B). These data indicate that cAMP reduces OTR ex-
pression in human myometrial cells via PKA. However,
whenPKAwasblocked (with either siRNAorantagonist),
forskolin increased OTR mRNA expression and protein
levels (Figure 2, C–F).
In the absence of PKA, cAMP acts via Epac1 to
increase OTR mRNA expression
To investigate how cAMP induced the increase inOTR
mRNA expression in the absence of PKA activity, we
knocked down PKA and added an Epac1 antagonist; this
combination blocked the forskolin-induced increase in
OTR mRNA expression (Figure 3A). Conversely, having
knocked down PKA, the addition of an Epac agonist
markedly enhanced the forskolin-induced increase in
OTR mRNA expression (Figure 3B). The Epac agonist
alone had aminimal effect onOTRexpression anddid not
change the ability of forskolin to repress OTR mRNA
expression (in the presence of PKA; Figure 3B). These data
demonstrate that when PKA activity is low, cAMP drives
OTR expression through Epac1.
cAMP levels and PKA activity are reduced and
Epac1 levels are increased with term labor
Next we studied how the different components of the
cAMPpathwaybehavedwith advancing gestation and the
onset of labor at term, specifically whenOTRmRNA and
protein levels peaked in early labor (Figure 1,AandB).We
found that the cAMP levels were highest in the term no
labor group but declined in early labor to the preterm no
labor levels and remained at this level in established labor
(Figure 4A). OTR mRNA and protein expression in-
creased with gestation and the onset of labor, reaching its
peak in the term early labor group, before it declined in the
term established labor group (Figure 1, A and B). PKA
regulatory subunit II (PKAR2) levelswerehighest in the
preterm no labor samples and declined progressively
thereafter (Figure 4, B and C). Epac1 mRNA levels in-
creased progressively from preterm no labor to term es-
tablished labor, peaking in the term established labor
myometrial samples (Figure 4D), but the protein levels
peaked in the term early labor samples (Figure 4E). In the
myometrium, we found the expression of Epac2 mRNA
was very low, whereas the expression of Epac1 mRNA
was much higher, and we therefore chose to restrict our
work to Epac1. GSmRNA expression was highest in the
term early labor samples andwas relatively reduced in the
term established labor samples (Supplemental Figure
11A), but the protein levels were unchanged across ges-
tation and the onset of labor (Supplemental Figure 11B).
A kinase-anchoring protein-79 (AKAP-79) mRNA levels
declined with advancing gestation and the onset of labor
(Supplemental Figure 11C) and protein levels showed a
similar trend, but the differences did not reach statistical
significance (Supplemental Figure 11D). Phospho-CREB
levels declined with advancing gestation, with the lowest
levels observed in the term established labor samples (Sup-
plemental Figures 11, E–G).
The effect of stretch and IL-1 on cAMP levels and
pathway components in uterine smooth
myometrial cells
Next, we investigated the possible mechanisms in-
volved in the changes in the cAMP effector pathway by
studying the impact of stretch and IL-1 stimulation alone
and in combination. We, and others, have used IL-1 ad-
ministration to myometrial cells in culture as a model for
myometrial inflammation previously (16, 18, 19), reca-
pitulating the elevated levels IL-1 observed in laboring
myometrial samples (20). As we have shown previously
(21, 22), stretch and inflammation alone increased OTR
protein levels (Supplemental Figures 12); however, the in-
Legend to Figure 2 Continued. . .
on individual data points. For panels A–D, the data were compared using a Wilcoxon matched-pairs test for data that were not normally
distributed and a paired t test for data that were normally distributed. For panels E and F, the data were compared using a Friedman’s test, with a
Dunn’s multiple-comparisons post hoc test for data that were not normally distributed and using an ANOVA, with a Bonferroni’s posttest for data
that were normally distributed. #, P  .05, ##, P  .01, ###, P  .001 when compared with control (n  6–9 in each experiment).
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crease inOTR levels inducedby the combinationof stretch
and inflammation was not greater than either stimulus
alone (Supplemental Figures 12). Stretch reduced basal
levels of cAMP, but this effect was not enhanced by in-
flammation (Figure 5A). The ability of forskolin to in-
crease cAMP levels was reduced by inflammation and
stretch, but again the combination of inflammation and
stretch did not increase this (Figure 5B). Stretch and in-
flammation alone or in combination had no effect on ei-
ther PKAR2 (Figure 5C) in Epac1 levels (Figure 5D).
Separately, Stretch and inflammation reduced the levels of
GS, AKAP-79, and phospho-CREB (Figures 5, E and F);
the reduction achieved by the combination of stretch and
inflammation in each casewas no greater than either stim-
ulus alone (Figures 5, E and F).
Discussion
The cAMP-signaling pathway is up-regulated in the hu-
man myometrium during pregnancy, contributing to the
maintenance of uterine quiescence until term (6).Our data
suggest that the changes in the cAMP effector pathways in
the myometrium before the onset of labor play a critical
role in regulatingOTR expression. Others have suggested
that PKA-mediated cAMP signaling may decline prior to
the onset of labor, with a reduction in myometrial AKAP-
79, PKAR2, and CREB (6, 23), but have not presented
evidence of an actual decline in cAMP/PKA function. Fur-
thermore, most of these studies have compared myome-
triumobtained fromwomenbefore the onset of laborwith
those obtained fromwomen in established labor,meaning
that the observed changes may actually be a cause or a
consequenceof labor. In thepresent study,we investigated
whether there was any evidence of a reduction in cAMP
function in early labor by assessing the mRNA expression
of 11 cAMP-responsive genes in myometrial samples
taken from different stages of pregnancy and labor. We
found that there is a decline in repressive-effect cAMP
actionwith advancing gestational and labor. Importantly,
in terms of labor onset, we identified that myometrial
OTR expression was repressed by cAMP/PKA during
pregnancy and that not onlywas this
effect lost with advancing gestation
but also the effect of cAMP was ac-
tually reversed in early labor, with
cAMP acting via EPAC1 to increase
OTRexpression (summarized inFig-
ure 6).
The myometrial oxytocin system
plays a key role in determining the
contractile status of the myome-
trium. OTR expression has been
widely studied as a marker of labor
in animalmodels of parturition (24–
26). However, the data in human la-
bor have been conflicting (27–31).
Our clinical experience suggests that
the uterus becomes more sensitive to
OT with advancing gestation as la-
bor approaches (32). These observa-
tions correlate with the concomitant
up-regulation of uterine OTR
mRNA levels (33), which reach a
peak during early labor and decline
thereafter (34). Although some
groups find that OTR expression is
increased in human labor, others do
not, instead suggesting thatOTR ex-
pression increases with advancing
gestationonly (31).Our results show
that OTR levels increase with gesta-
tion, reaching a peak in early labor
Figure 3. In the absence of PKA, cAMP works via Epac1 in increasing OTR gene expression. A,
Myometrial cells were isolated from myometrial biopsies obtained from women at the time of
term prelabor cesarean section. Cells were cultured and incubated. PKAC- was knocked down
using siRNA (siPKAC-; controlled with nontargeted siRNA [siNT]). After transfection, cells were
incubated for 96 hours before being treated with forskolin (100 M) or brefeldin A (100 M),
either alone or in combination for 6 hours; mRNA were extracted, and the levels of OTR mRNA
were measured using RT-PCR. B, In a separate experiment, myometrial cells were isolated as
described above. PKAC- was knocked down using siRNA (siPKAC-; controlled with
nontargeted siRNA [siNT]). After transfection, cells were cultured for 96 hours before being
treated with forskolin (100 M) or 8pCPT-2-O-Me-cAMP (50 M), either alone or in
combination for 6 hours; mRNA were extracted, and the levels of OTR mRNA were measured
using RT-PCR. Data are shown as the median and interquartile range superimposed on individual
data points and were compared using a Friedman’s test, with a Dunn’s multiple-comparisons
post hoc test for data that were not normally distributed and using an ANOVA, with Bonferroni’s
posttest, for data that were normally distributed (A and B). #, P  .05 when compared with
control (n  6–9 in each experiment).
tapraid4/zee-end/zee-end/zee01116/zee8675-16z xppws S5 9/29/16 15:32 Art: EN-16-1514 Input-ss
doi: 10.1210/en.2016-1514 press.endocrine.org/journal/endo 7
F5
F6
before declining in established labor, consistent with pre-
vious observations of a decline in OTR with labor dura-
tion (34) and explaining the inconsistencies between stud-
ies of OTR expression with labor, which have not
controlled for the duration or stage of labor. We have
linked the observation of an increase in OTR expression
with advancing gestation and the onset of labor to a re-
duction of cAMP/PKA action through in vitro studies,
which demonstrated that cAMP inhibits OTR expression
viaPKA.KnockdownofPKAnotonly reversed the cAMP-
induced reduction in OTR repression but also resulted in
an increase in OTR expression mediated via cAMP acti-
Figure 4. cAMP and PKA levels are reduced and Epac1 levels are increased with term labor. Human myometrial tissue samples were collected
from different groups of nonlaboring and laboring women at the time of cesarean section. Women were recruited in four defined groups: preterm
not in labor (PTNL; 24–36 wk), TNL (37 wk), term early labor (TEaL; three to four contractions in 10 min and  3 cm dilated cervix), and term
established labor (TEsL; three to four contractions in 10 min and  3 cm dilated cervix). Samples were snap frozen and stored at 80°C until
mRNA and protein extraction. A, Myometrial tissue was ground in a mortar and pestle under liquid nitrogen, and a cAMP assay was subsequently
performed using the cAMP chemiluminescent immunoassay kit (Arbor Assays) following the manufacturer’s instructions. The levels of PKAR2 and
Epac1 mRNA (B and D) and protein (C and E) were measured using quantitative RT-PCR and Western blotting, respectively. A representative
Western blot is shown above each graph displaying the densitometry of the protein levels. Blots were probed with PKAR2 and Epac1 antibody,
and GAPDH was used as a loading control. Data are shown as the median and interquartile range superimposed on individual data points and
were compared using a Friedman’s test, with a Dunn’s multiple-comparisons post hoc test for data that were not normally distributed and using
an ANOVA, with Bonferroni’s posttest, for data that were normally distributed. #, P  .05, ##, P  .01 (n  12 in each group).
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Figure 5. The effect of stretch, inflammation, and their combination on cAMP levels and components of the cAMP pathway in uterine smooth
myometrial cells. Myometrial cells were isolated from myometrial biopsies obtained from women at the time of prelabor term cesarean section.
Myometrial cells were grown up to passage 3 and plated on to the stretched plates. Cells were stretched for 30 hours in total. After 24 hours, cells
were incubated for an additional 6 hours in the absence and presence of IL-1 (1 ng/mL), either alone or in combination. Proteins were then
extracted and the levels of PKAR2, GS, AKAP-79, phospho-CREB, and Epac1 were measured using Western blotting. Blots were probed with
PKAR2, GS, AKAP-79, phospho-CREB, and EPAC1 antibodies, and GAPDH was used as a loading control (panels C–G). In the case of cAMP
(panels A and B), a further experiment was performed with the addition of forskolin (100 M) to stretch and IL-1-treated cells; the supernatants
were collected and cAMP levels (picomoles per milliliter) were measured using an assay kit (cAMP assay; R&D Systems) following the
manufacturer’s instructions (panels B and C). Data are shown as the median and interquartile range superimposed on individual data points and
were compared using a Friedman’s test, with a Dunn’s multiple-comparisons post hoc test for data that were not normally distributed, and using
an ANOVA, with a Bonferroni’s posttest, for data that were normally distributed. #, P  .05, ##, P  .01, ###, P  .001 when compared with
control (n  6–9 in each experiment).
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vation of Epac. These data support our hypothesis that a
reduction in the cAMP/PKA pathway is key to the initia-
tion of the labor process and introduce the idea of a mo-
lecular switch in cAMPaction,mediated through adecline
in PKA and an increase in Epac1 levels, which drivesOTR
expression, promoting labor onset. Prolonged incubation
with prostaglandin (PG)-I2-enhanced, oxytocin-induced
myometrial contractility acting via cAMP/PKA to increase
procontractile proteins including the gap junction protein
connexin43 (35).These data raise thepossibility that PKA
and EPAC act in concert to promote a prolabor myome-
trial phenotype.
We found that cAMP/PKA activity declined inmyome-
trial samples with advancing gestation in parallel with a
decline in PKA levels. Europe-Finner et al (4) showed that
GS declined with the onset of labor, possibly via in-
creased nuclear factor-B (36) or decreased progesterone
activity (37), and this might be responsible for our ob-
served decline in cAMP/PKA activity. The adenylyl cycla-
ses are downstream of GS, but there are no data regard-
ing myometrial adenylyl cyclase levels with the onset of
labor, although some isoforms are reported to increase
with gestation (38). The phosphodiesterases (PDEs) are
repressed during pregnancy, probably by the high levels of
estrogen and progesterone (39, 40). PDE class IV is the
most important in human myometrium, and we found
that the levels of PDE4B increased in late pregnancy, per-
haps contributing to the decline in cAMP levels.
When we studied the cAMP effector pathway in myo-
metrial tissues with advancing gestation and the onset of
labor, we, like others, found that cAMP, PKA, GS, and
AKAP-79 declined (4, 7), resulting in a decrease in the
cAMP/PKA pathway activity, as shown by the reduction
in CREB phosphorylation. Simultaneously with the de-
cline in PKAactivity in early labor, Epac1 levels increased,
associated with a further increase in OTR levels. We re-
produced this in our in vitro studies, knocking down PKA
and adding an Epac agonist, and found a marked up-reg-
ulation of OTR expression (Figure 3B). These observa-
tions suggest that the changes in the cAMP effector path-
way may control OTR expression and the onset of labor.
Previously we found that both stretch and inflamma-
tion increasedOTRmRNAexpression inprimary cultures
of myometrial cells (21, 22). Similarly, in animal studies,
stretch (24, 26, 41) and inflammation (42) have been
shown to up-regulateOTR expression. Also, several stud-
ies have shown that inflammation represses cAMP levels
(43–45). Consequently, we used primary cultures of hu-
manmyometrial cells to investigate the role of stretch and
inflammation in the changes observed in the myometrial
cAMP effector pathwaywith the onset of labor.We found
that stretch and inflammation increased OTR expression
and reduced the levels of cAMP,
AKAP-79, GS, and phospho-
CREB. However, although the de-
cline in phospho-CREB implies a re-
duction in PKA activity, the levels of
PKAR2 (and Epac1) were unaf-
fected by stretch or inflammation.
These data suggest that either pro-
cess can induce some, but not all, of
the changes in the cAMP pathway
that occur with the onset of labor.
Understanding the regulation of
PKA and EPAC expression is the
next step in defining the role of the
cAMP effector pathway in human
labor.
Initially, we identified that in
myometrial cells, cAMP up-regu-
lated MAPK phosphatase-1 (MKP-
1), 11-hydroxysteroid dehydroge-
nase type1 (HSD1), PTGES,PDE4B,
G protein-coupled receptor (GPR)-
125, and down-regulated PRKG1,
GUCY1A3, GPR124, CREB3L1,
and OTR. The increase in MKP-1, a
phosphatase, which represses the ac-
Figure 6. Proposed theory for cAMP action in term myometrium. In pregnancy, high levels of
cAMP act via a PKA-dependent pathway to reduce OTR levels and consequently, oxytocin (OT)-
driven intracellular calcium release, promoting myometrial quiescence. In early labor, the activity
of the cAMP/PKA pathway is reduced and, coincidently, the activity of the cAMP/Epac pathway is
increased, and the combination results in increased OTR levels and consequently OT-driven
intracellular calcium release, promoting myometrial contractility and the onset of labor.
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tivity ofMAPK/activator protein-1, and11HSD1,which
metabolizes inactive cortisone to active cortisol, would be
consistentwithanantiinflammatory,progestational effect
in the myometrium. In contrast, the increase in PTGES
would increase PGE2 levels and might be expected to in-
crease myometrial contractility (46). However, PGE2 has
been shown to be prorelaxant and antiinflammatory, act-
ing via endogenous prostanoid-2 and the generation of
cAMP (47); furthermore, clinically, the inhibition of cy-
clooxygenase-2 in a cohort of women considered to be at
high risk of PTLactually tended to increase the risk of PTL
(28% vs 33%) (48), suggesting that the effect of prosta-
glandins may vary during pregnancy. Indeed, conversely,
as mentioned above, Fetalvero et al (35) showed that pro-
longed incubation with PGI2 (a prorelaxant prostaglan-
din) actually enhanced myometrial strip contractility act-
ing via cAMP/PKA. The increase in PDE4B would be
consistent with the activity of a feedback loop and has
been reported in other smooth muscle cells (49). In terms
of the repressed genes, other than OTR, which we have
exploredanddiscussedabove, PRKG1andGUCY1A3are
part of the cGMP pathway (the former is a cGMP-depen-
dent protein kinase,which acts to promote smoothmuscle
relaxation, and the latter acts to convert GTP to cGMP),
and their repression may be part of the cross talk between
cAMP and cGMP, which is recognized in other situations
(50). CREB3L1 is involved in the cAMP signaling path-
way and may be part of the negative feedback associated
with cAMP/PKA pathway activation. Both GPR124 and
GPR125 are orphan G protein receptors with no known
function.
In summary, our data reveal that myometrial quies-
cence in pregnancy is characterized by high cAMP tone
and that this is associated with the reduction of the OTR
level via the PKA-dependent pathway. On the other hand,
the decline in the activity of the cAMP/PKA pathway and
an increase in Epac1 levels with advancing gestation and
the onset of labor result in increasedOTR expression pro-
moting uterine contractility (Figure 6). This has important
implications for the design of treatment strategies for the
prevention of preterm labor and suggests the cAMP/PKA
agent as a novel therapeutic target.
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